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1. INTRODUCTION 
Transitions in the energy-state of biological sys- 
tems are most often elicited by oxygen pulses, light 
pulses or uncouplers. The study of the changes ac- 
companying such transitions greatly contributed to 
the understanding of the mechanism of energy- 
transduction. Transitions induced by light or oxy- 
gen pulses are reversible. In contrast, the reversal 
of the de-energization evoked by uncouplers i , as 
a rule, troublesome. We encountered this difficulty 
while using the powerful protonophoric un- 
couplers [2] FCCP or S-13 for de-energization in a 
study of the respiration-driven ion fluxes in a 
halotolerant bacterium, Bal. Anions of pro- 
tonophoric uncouplers form stable, ternary com- 
plexes with valinomycin-K + [3-6]. Thus, we have 
tried to utilize complex formation as a tool for the 
reversal of the uncoupler-induced perturbation. 
Here, we show that in bacterium Bal, the inter- 
ference of FCCP or of S-13 with energy-linked 
functions can be abolished with the aid of val- 
Abbreviations: FCCP, carbonyl cyanide p-trifluorometh- 
oxy-phenylhydrazone; S-13,2,5-dichloro-3-(tert-butyl)- 
4'nitrosalicylanilide; 9-AA, 9-aminoacridine; Dis-C3- 
(5), 3,3'-dipropylthiodicarbocyanine iodide; Hepes, N-2- 
hydroxyethylpiperazine-N'-2-ethanesulfonic acid; Q- 
9AA, % change in the fluorescence of 9-aminoacridine; 
Q-Dis, % change in the fluorescence ofDis-C3-(5); ApH, 
trans-membrane pH-gradient; A,/,, membrane potential; 
AI600 nm, initial rate of change in the light scattering at 
600 nm (arbitrary units) 
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inomycin. The applicability of this method of 're- 
coupling' may be extended to systems, which are 
relatively insensitive to valinomycin per se, as is 
the case with the bacterium, Bal [7]. 
2. MATERIALS AND METHODS 
Hepes, valinomycin and FCCP were products of 
Sigma Chemical Co. (St Louis MO); Dis-C3-(5) 
and S-13 were generous gifts from Professor L. 
Ernster, University of Stockholm (Stockholm). 
Bacterium, Ba I was grown and harvested as in 
[1] for the 'high salt-grown' organism. 'KCl-load- 
ed' cells were prepared by washing the harvested 
cells repeatedly with 0.8 M KC1 at 0°C. To mea- 
sure the rate of volume changes elicited by energy- 
dependent extrusion of KC1 from the cells, the 
light scattering method in [1] was used. The cross- 
membranal ApH and A,/, were assessed with the 
aid of the fluorescent dyes 9-AA and Dis-C3-(5), 
respectively [8,9]. 
Light scattering and fluorescence were measured 
in a Perkin-Elmer fluorescence spectrophotometer, 
model MPF-44B. Absorption spectra were taken 
with a DW-2aUV-Vis spectrophotometer. Oxygen 
was assayed polarographically, ATP as in [10] and 
protein as in [11]. For other experimental details 
see figure and table legends. 
3. RESULTS AND DISCUSSION 
According to [3] complex formation between 
FCCP and valinomycin-K + is reflected by a shift 
in the absorption peak of the uncoupler. In the 
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effect on the kinetics of changes in light scattering. 
However, when valinomycin was added subse- 
quently to the assay system containing the un- 
coupler, a gradual reactivation of the pump ac- 
tivity occurred. Valinomycin was also found to 
abolish the effect of the uncoupler S-13 under con- 
ditions which were analogous to that in fig.2 (not 
shown). 
To assess the connection between the restoration 
of the pump activity and the formation of the un- 
coupler-valinomycin-K + complex the titration in 
fig.3 was done: [FCCP] was constant while [val- 
inomycin] varied. The absorbancy at 415 nm (in- 
dicating the formation of the complex) and the 
light scattering (reflecting the pump activity) 
changed in a near-parallel manner, thus suggesting 
Fig.l. Spectral evidence for the interaction between 
FCCP and valinomycin. The sample cell contained in a 
3.0 ml total vol. 30 mM Hepes (pH 7.0), 0.67 ~M FCCP 
and 0.8 M KCI or NaC1 as indicated. FCCP was omitted 
from the reference cell. When indicated, 1.52 t~M val- 
inomycin was also added both to the sample cell and the 
reference cell. After 5 min incubation the difference 
spectra were recorded. Curves: KCI + FCCP (1); 
KCI + FCCP + valinomycin (2); NaC1 + FCCP (3); 
NaCI + FCCP + valinomycin (4). 
presence of 0.8 M KC1, which was the major salt 
constituent of the standard assay medium, val- 
inomycin caused a shift in the absorption peak of 
FCCP from 381-415 nm (fig.l). No shift was ob- 
served when NaC1 replaced the potassium salt. 
Under conditions similar to fig.l, the protono- 
phore S-13 also interacted with valinomycin-K +. 
Here the shift in the absorption peak was from 
382-428 nm (not shown). 
The feasibility of 'recoupling' by valinomycin 
was first tested on energy-dependent extrusion of 
salt from cells of Bal, pre-loaded with KC1. Details 
about this pump activity leading to contraction of 
the cytoplasm were given in [1]. It can be most 
conveniently followed by monitoring the changes 
in light scattering. The pump became functional 
when the cells were introduced in the assay medi- 
um containing the respiratory substrate (fig.2). 
FCCP nearly completely suppressed the volume 
contraction, whereas valinomycin by itself had no 
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Fig.2. Effect of FCCP and of valinomycin on salt extru- 
sion from cells of Bal, preloaded with 0.8 M KC1. The 
optical cell contained in 3.0 ml total vol. 30 mM Hepes 
(pH 7.0), 0.8 M KC1 and 50 mM ethanol at 37°C. When 
indicated also 0.67 /~M FCCP and/or 1.52 btM val- 
inomycin were added. The reaction was started by 
adding the bacterial cells (0.1 mg protein/ml). The 
kinetics of the change in light scattering (•6oo nm) was 
monitored. Curves: no addition (1); valinomycin (2); 
FCCP (3); FCCP followed by valinomycin at the time 
indicated by arrow (4). 
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Table 1 
Reversal of uncoupling by valinomycin 
Addi- Respiration ATP Q-9AA Q-Dis Z~r600 nm 
tions a (natom O/min) (nmol) (%) (%) (arb. units) 
-val. +val. -val. +val. -val. +val. -val. +val -val. +val 
None 144.0 130.0 4.0 3.9 7.1 7.5 41.0 41.0 26.5 21.5 
FCCP 494.0 219.0 0.9 3.2 1.9 6.6 0.0 30.0 0.0 20.5 
S-14 562.0 178 .0  . . . . . .  0.0 18.4 
a In all the assays the basic medium contained 30 mM Hepes (pH 7.0), 0.8 M KCI and 
50 mM ethanol 
Cells ofBa] preloaded with 0.8 M KCI were added in the following amounts: 1 mg pro- 
tein/ml for ATP, Q-9AA and Q-Dis assays; 0.5 mg protein/ml to measure respiration and 
0.1 ml protein/ml to assess AI600 nm' When indicated also the following additions were 
made: FCCP, 0.67/~M; S-13, 4.43/LM; 9AA, 1.60/~M; Dis-C3-(5), 3.6/LM and 
valinomycin (val.), 1.52 ttM. All the results were calculated for 1 mg protein 
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Fig.3. Restoration of pump activity as a function of the 
valinomycin concentration. Pump activity was measured 
as in fig.2. The optical cell contained 30 mM Hepes (pH 
7.0), 0.8 M KCI, 50 mM ethanol, 0.57 ~M FCCP and 
valinomycin at the concentrations indicated. The reac- 
tion was started by adding cells of Bal (0.1 mg protein/ 
ml) pre-loaded with 0.8 M KCI to the assay medium: 
absorbancy at415 nm; (---) AI600 nm" 
a cause-effect relation between the above two 
parameters (fig.3). 
Additional functions connected with energy 
transduction which were also tested as to their re- 
sponse to valinomycin-K + are shown in table 1. 
An inspection of the data reveals that valinomycin 
in presence of K + abolished the release of the res- 
piratory control induced by FCCP or S-13, re- 
plenished the ATP pool depleted by FCCP, re- 
stored ApH and A,/, which were depressed by 
FCCP. 
Valinomycin-K +, by forming complexes with 
protonophores, effectively reversed the uncoupling 
effect of the latter on several energy-linked func- 
tions in the halotolerant bacterium, Bal. After 
being sequestered by valinomycin-K +, the anion 
of the protonophore appears to be prevented from 
exerting its action; i.e., to short-circuit he cross- 
membrane proton current [12]. Gram-negative 
bacterial cells are known to be relatively insensi- 
tive toward valinomycin, unless pretreated with 
EDTA [13]. It is, thus, likely that valinomycin-K +
could also be used for recoupling in several other 
bacterial systems. 
In several cases the effectiveness of a pro- 
tonophore as an uncoupler was found to be poten- 
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tiated, rather than decreased by the simultaneous 
presence of a cationophore-cation complex [14]. 
The phenomenon of potentiation was explained by 
the assumption that the abolition of A,/, by elec- 
trophoretic ounter-flow of the positively charged 
cationophore-cation complex facilitated the pro- 
tonophore-mediated passive backflow of protons. 
It is therefore apparent hat neutralization of the 
net positive charge of the former complex by a di- 
rect interaction with the protonophore-anion 
would prevent he potentiation. Thus, it is reason- 
able to assume, that it will depend on the proper- 
ties of the coupling-membrane and/or the condi- 
tions of the assay (i.e., the mutual affinity between 
the 2 types of agents, their stoichiometry, the con- 
centration of the cation) whether the concerted ac- 
tion of a protonophore and a positively charged 
cationophore will result in an enhancement or a 
diminution of the extent of uncoupling. 
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